Integra LifeSciences Corporation
IART | NASDAQ
$15.96
+$0.37 (+2.37%)
Sep 22, 2026, 2:43 PM ET · Market open
Company Profile
Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.
Key Executives
| Name | Position |
|---|---|
| Stuart Essig | CEO, President & Chairman |
| Lea Daniels Knight | Executive Vice President & Chief Financial Officer |
| Michael D. Hutchinson | Executive Vice President, Chief Legal Officer & Secretary |
| Teshtar Elavia | Corporate VP & Chief Technology Officer |
| Christopher Ward | Senior Director of Investor Relations |
| Harvinder Singh | Executive Vice President & President of International Business |
| Jeffrey Mosebrook | Senior Vice President of Finance & Principal Accounting Officer |
| Laurene Isip | Vice President of Global Corporate Communications & Public Relations |
| Michael J. McBreen | Executive VP & Chief Commercial Officer |
| Robert T. Davis Jr. | Executive Vice President of Tissue Reconstruction and Distributed Technologies |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 04, 2026 | 4 | Filing |
| Aug 13, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jul 31, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Jul 29, 2026 | 10-Q | Quarterly Report |
| Jul 29, 2026 | 8-K | Current Report |
| Jul 06, 2026 | 4 | Filing |
| Jul 06, 2026 | 4 | Filing |
| Jul 06, 2026 | 4 | Filing |
| Jul 06, 2026 | 4 | Filing |
| May 29, 2026 | SD | Filing |
Integra LifeSciences Corporation
| Country | United States |
| IPO Date | Aug 15, 1995 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 4,427 |
| CEO | Stuart Essig |
Contact Details
1100 Campus Road Princeton,
New Jersey 08540 United States
Stock Details
| Ticker Symbol | IART |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000917520 |
| CUSIP Number | 457985208 |
| ISIN Number | US4579852082 |
| SIC Code | 3841 |
Recent News
- 5 days ago / zacks.comHere's Why Integra LifeSciences (IART) is a Strong Value Stock
- 6 days ago / seekingalpha.comIntegra LifeSciences Holdings Corporation (IART) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- 25 days ago / zacks.comIntegra (IART) Down 1.6% Since Last Earnings Report: Can It Rebound?
- 26 days ago / zacks.comWhy Integra LifeSciences (IART) is a Top Value Stock for the Long-Term
- 1 month ago / zacks.comCan IART's SurgiMend Relaunch Help Drive a Broader 2027 Recovery?
- 1 month ago / zacks.comIs IART Still Attractive as Its Low Valuation Meets Execution Risks?
- 2 months ago / zacks.comHere's Why Integra LifeSciences (IART) is a Strong Momentum Stock
- 2 months ago / seekingalpha.comIntegra LifeSciences Holdings Corporation (IART) Q2 2026 Earnings Call Transcript
- 2 months ago / zacks.comIntegra (IART) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
- 2 months ago / marketbeat.comIntegra LifeSciences Q2 Earnings Call Highlights
Add to Watchlist
Select watchlists to add or remove IART